Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel ADIR compounds active in vitro and in vivo as antitumor agents

Jan. 12, 2000

U.S. university researchers design improved trans-platinum complexes

Jan. 12, 2000

NCI begins additional trial of Genta's bcl-2 antisense compound

Jan. 12, 2000

Cell Therapeutics adds late-stage development compound to pipeline

Jan. 12, 2000

Ribonucleotide reductase R2-targeting antisense oligonucleotides for neoplastic diseases

Jan. 12, 2000

Alfa Wassermann will market and distribute Ligand's oncology products in Italy

Jan. 12, 2000

Canstatin is a potent angiogenesis inhibitor in preclinical models

Jan. 12, 2000

Synthesis and biological activity of new radicicol derivatives presented by Kyowa Hakko

Jan. 11, 2000

Millennium reports discovery of apoptosis-linked proteins

Jan. 11, 2000

ADNF III/ADNP antisense oligonucleotides available for licensing from NIH

Jan. 11, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...